Hogan Lovells 2024 Election Impact and Congressional Outlook Report
Jane Summerfield
Partner Global Regulatory
Languages
English
Jane also advises on commercial contractual arrangements, including consultancy, sponsorship, co-promotion, collaboration, manufacturing, distribution, services, quality and pharmacovigilance agreements.
Jane works with clients to resolve issues with UK enforcement authorities and regulatory bodies, including the Medicines and Healthcare products Regulatory Agency (MHRA), Prescription Medicines Code of Practice Authority (PMCPA), Advertising Standards Authority (ASA), and Trading Standards.
Jane combines a scientific background with deep regulatory knowledge and a commercial approach, providing "clear responses with business impact" Chambers UK.
Advising various multinational pharmaceutical companies on the regulatory requirements relating to marketing authorisations & manufacturing, import & wholesale dealer licences
Advising an international healthcare services provider on the regulatory requirements governing the provision of remote medical services.
Advising a UK pharmaceutical manufacturer on the regulation of the authorisation, pricing and reimbursement, and sale and advertising of medicinal products in the UK.
Advising a U.S. pharmaceutical manufacture on EU & UK SOPs covering approval of marketing materials & activities, hospitality, promotional gifts, samples & medical advisory boards
Advising an internet-based consumer goods retailer on competitor challenges to price claims and a Trading Standards challenge to its on-line ordering process for selling age restricted products.
Advising a leading soft drinks manufacturer on labelling and compositional legislation, advertising copy and defending challenges to products and advertising materials by regulatory authorities.
Advising a UK pharmaceutical company on a co-promotion agreement involving the joint promotion of a new treatment with another major pharmaceutical manufacturer.
Advising a medical device manufacturer on an innovative risk share agreement with a prime contractor supplying services to a Clinical Commissioning Group.